Our company's imported active pharmaceutical ingredient (API) Furosemide has officially received marketing approval from the National Medical Products Administration (NMPA). Covering injectable and oral formulations, the product meets international quality standards, providing domestic formulation manufacturers with a stable, compliant supply of high-quality API.
Committed to professionalism and efficiency, we continue to source premium imported APIs to support our partners in accelerating R&D and regulatory filing. Pharmaceutical enterprises and R&D institutions are welcome to explore collaboration opportunities.